Table of Contents Table of Contents
Previous Page  811 / 1173 Next Page
Information
Show Menu
Previous Page 811 / 1173 Next Page
Page Background

1/03/2016

20

Summary clinical data

Re-irradiation is an option for patients with recurrent

or second tumors

Risk of normal tissue damage and impact on quality

of life must be taken into account

Take home messages

If tolerance has already been exceeded: no re-

irradiation possible without loss of function

Early effects

Low to moderate doses:

Restitution of original tolerance may be complete after tissue-

specific and dose-dependent time intervals

High doses:

Residual damage may remain for longer intervals, particular at the

stem cell level, which is not necessarily reflected in functional tissue

compartments

40